Emmes Group Earns ISO 27001:2022 Certification for Data Security

The commendation from the International Organization for Standardization (ISO) underscores Emmes Group’s dedication to delivering secure, innovative, and data-driven solutions to its biotech and pharmaceutical partners.

Commenting on the accreditation, Scott Hospes VP of Enterprise Security, Applications and Technology at Emmes Group, said: “We are increasingly now in an age of incredibly data-rich trials, with data gathering and analysis as an integral part of accelerating development timelines and lowering trials costs. Achieving ISO/IEC 27001:2022 certification reflects our dedication to the highest standards of information security and the most up-to-date best practices. This independent verification fosters greater trust in our data handling processes and solidifies our position as a leader in the industry’s transformation toward AI-driven and digital-native clinical research.”